Notice Title

Consent to the Distribution of New Medicines

Publication Date
19 Oct 2017

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2017-go5394

Issue Number

106
Title
View PDF
File Type and Size
PDF (28 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Herclon
Trastuzumab 150mg
Powder for infusion
Roche Products (NZ) Limited
Roche Diagnostics GmbH, Mannheim, Germany
F Hoffmann-La Roche Limited, Basel, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Herclon
Trastuzumab 440mg
Powder for infusion
Roche Products (NZ) Limited
F Hoffmann-La Roche Limited, Basel, Switzerland
Genentech Inc, California, United States of America
Genentech Inc, Oregon, United States of America

Dated this 12th day of October 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).